Skip to content

The effect of ingesting a whey and collagen protein blend on myofibrillar and connective tissue protein synthesis rates at rest and during recovery from exercise

The effect of ingesting a whey and collagen protein blend on myofibrillar and connective tissue protein synthesis rates at rest and during recovery from exercise - Blend Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51634
Enrollment
38
Registered
2022-07-04
Start date
2022-09-13
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle and connective tissue research (no disorders) Connective tissue Muscle health

Interventions

Participants will perform unilateral resistance exercise followed by the ingestion of either 30 g of a protein blend or a non-caloric placebo (flavored water). Continuous intravenous tracer infusion

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Males - Aged between 18-35 years - Healthy, recreationally active (performing exercise between 1 and 4 times per week in the past 6 months) - BMI 18.5 - 30 kg/m2 - No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).

Exclusion criteria

Exclusion criteria: - Females - Musculoskeletal disorders - Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications). - Participation in any structured regular exercise program - Chronic use of gastric acid suppressing medication or anti-coagulants - Pathologies of the gastrointestinal tract - Blood donation in the past 2 months

Design outcomes

Primary

MeasureTime frame
- Myofibrillar protein-bound L-[ring-13C6] phenylalanine enrichment (expressed as MPE) - Muscle connective tissue protein-bound L-[ring-13C6] phenylalanine enrichment (expressed as MPE) - Average plasma L-[ring-13C6] phenylalanine enrichment over the 3.5 h period before the study beverage and 5 h postprandial period.

Secondary

MeasureTime frame
* Plasma amino acid concentrations (expressed as *mol/L) * Total plasma amino acids (AAmax [*mol/L]) * Plasma glucose (glucosemax [mmol/L]) * Plasma insulin (insulinmax [mU/L])

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)